JP2020518636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518636A5 JP2020518636A5 JP2019560362A JP2019560362A JP2020518636A5 JP 2020518636 A5 JP2020518636 A5 JP 2020518636A5 JP 2019560362 A JP2019560362 A JP 2019560362A JP 2019560362 A JP2019560362 A JP 2019560362A JP 2020518636 A5 JP2020518636 A5 JP 2020518636A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation according
- formulation
- insulin
- zinc
- monovalent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023014791A JP2023071660A (ja) | 2017-05-05 | 2023-02-02 | 新規の製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1707187.9 | 2017-05-05 | ||
| GBGB1707187.9A GB201707187D0 (en) | 2017-05-05 | 2017-05-05 | Novel formulations |
| PCT/GB2018/051178 WO2018203060A2 (en) | 2017-05-05 | 2018-05-03 | Novel formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023014791A Division JP2023071660A (ja) | 2017-05-05 | 2023-02-02 | 新規の製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020518636A JP2020518636A (ja) | 2020-06-25 |
| JP2020518636A5 true JP2020518636A5 (https=) | 2021-06-17 |
| JP7534850B2 JP7534850B2 (ja) | 2024-08-15 |
Family
ID=59065623
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560362A Active JP7534850B2 (ja) | 2017-05-05 | 2018-05-03 | 新規の製剤 |
| JP2023014791A Pending JP2023071660A (ja) | 2017-05-05 | 2023-02-02 | 新規の製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023014791A Pending JP2023071660A (ja) | 2017-05-05 | 2023-02-02 | 新規の製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200093894A1 (https=) |
| EP (1) | EP3618804A2 (https=) |
| JP (2) | JP7534850B2 (https=) |
| CN (1) | CN110636832A (https=) |
| GB (1) | GB201707187D0 (https=) |
| WO (1) | WO2018203060A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201607918D0 (en) | 2016-05-06 | 2016-06-22 | Arecor Ltd | Novel formulations |
| DK3518892T5 (da) | 2016-09-29 | 2024-09-02 | Arecor Ltd | Farmaceutisk formulering, der indeholder en insulinforbindelse |
| CA3094304A1 (en) * | 2018-04-04 | 2019-10-10 | Arecor Limited | Medical infusion pump system for the delivery of an insulin compound |
| IL277721B2 (en) | 2018-04-04 | 2024-03-01 | Arecor Ltd | Medical infusion pump system for the delivery of an insulin compound |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| KR910700262A (ko) | 1988-12-23 | 1991-03-14 | 안네 제케르 | 사람 인슐린 유사체 |
| PT93057B (pt) | 1989-02-09 | 1995-12-29 | Lilly Co Eli | Processo para a preparacao de analogos da insulina |
| JP3122128B2 (ja) * | 1989-12-21 | 2001-01-09 | ノボ ノルディスク アクティーゼルスカブ | ペプチド製剤 |
| US5866538A (en) | 1996-06-20 | 1999-02-02 | Novo Nordisk A/S | Insulin preparations containing NaCl |
| DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
| JP5599543B2 (ja) * | 2002-05-07 | 2014-10-01 | ノヴォ ノルディスク アー／エス | 単量体インスリン及びアシル化インスリンを含む可溶性製剤 |
| US8084022B2 (en) | 2006-06-23 | 2011-12-27 | Aegis Therapeutics, Llc | Stabilizing alkylglycoside compositions and methods thereof |
| US8173594B2 (en) * | 2006-06-23 | 2012-05-08 | Aegis Therapeutics, Llc | Stabilizing alkylglycoside compositions and methods thereof |
| GB0700523D0 (en) | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
| US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| AU2010264636B2 (en) | 2009-06-26 | 2013-06-27 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and an amino acid |
| US20120178675A1 (en) | 2010-07-07 | 2012-07-12 | Biodel Inc. | Compositions And Methods For Modulating The Pharmacokinetics and Pharmacodynamics of Insulin |
| JP2013545782A (ja) * | 2010-12-14 | 2013-12-26 | ノヴォ ノルディスク アー／エス | 長時間作用型インスリンと組み合わせた速効型インスリン |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| WO2013186138A1 (en) * | 2012-06-14 | 2013-12-19 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and arginine |
| TWI780236B (zh) * | 2013-02-04 | 2022-10-11 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
| WO2015106269A2 (en) * | 2014-01-13 | 2015-07-16 | Thermalin Diabetes, Llc | Rapid action insulin formulations and pharmaceutical delivery systems |
| WO2015120457A1 (en) | 2014-02-10 | 2015-08-13 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
| TWI685348B (zh) | 2014-05-08 | 2020-02-21 | 美國禮來大藥廠 | 速效胰島素組合物 |
| GB201607918D0 (en) * | 2016-05-06 | 2016-06-22 | Arecor Ltd | Novel formulations |
-
2017
- 2017-05-05 GB GBGB1707187.9A patent/GB201707187D0/en not_active Ceased
-
2018
- 2018-05-03 WO PCT/GB2018/051178 patent/WO2018203060A2/en not_active Ceased
- 2018-05-03 JP JP2019560362A patent/JP7534850B2/ja active Active
- 2018-05-03 EP EP18723926.4A patent/EP3618804A2/en active Pending
- 2018-05-03 US US16/610,805 patent/US20200093894A1/en not_active Abandoned
- 2018-05-03 CN CN201880029092.2A patent/CN110636832A/zh active Pending
-
2023
- 2023-02-02 JP JP2023014791A patent/JP2023071660A/ja active Pending
-
2025
- 2025-01-03 US US19/009,689 patent/US20250268987A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518636A5 (https=) | ||
| JP2019529506A5 (https=) | ||
| JP7093669B2 (ja) | 即効型インスリン組成物 | |
| EP4306168B1 (en) | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals | |
| JP2019533656A5 (https=) | ||
| RU2527327C2 (ru) | Лекарственные средства, содержащие фторхинолоны | |
| JP5372523B2 (ja) | 真菌症治療用ゲル組成物 | |
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| RU2466715C2 (ru) | Фармацевтические композиции и способ лечения воспаления у крупного рогатого скота и других животных | |
| JP2016539921A5 (https=) | ||
| KR890002240B1 (ko) | 퀴놀론 카복실산의 수성 염기성 제제를 제조하는 방법 | |
| JP2014507484A (ja) | ペプチド薬物の非経口注射用の安定な製剤 | |
| EP2525796A2 (en) | Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease | |
| US20150080387A1 (en) | Medicament formulations comprising fluoroquinolones | |
| JP2017514831A5 (https=) | ||
| KR20150021509A (ko) | 칼코게나이드를 포함하는 조성물 및 관련 방법 | |
| AU2021336289A1 (en) | Ionic liquid formulations for treating diabetes | |
| JP2020059747A (ja) | エピナスチン含有点眼液 | |
| TWI905111B (zh) | 含有對硼苯基丙胺酸之注射液劑 | |
| CA1134747A (en) | Medicinal formulation | |
| US20260091030A1 (en) | High-dose naloxone formulation | |
| WO2019226058A1 (en) | Medicinal product containing improved stability water solution of methisoprinol | |
| TW201219036A (en) | Transdermal preparation | |
| EP3579820A1 (en) | Liquid composition containing pradofloxacin | |
| US10350200B2 (en) | Aqueous suspensions of oximes for autoinjectors |